Publication | Closed Access

Structure–activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors

Molecular PharmacologyAldo-keto ReductaseBiochemistryMedicineRational Drug DesignStructure–activity RelationshipsPharmacologyMolecular ModelingAldose Reductase InhibitorsDrug Discovery